KMC Speciality Hospitals Intrinsic Value
KMC Speciality Hospitals (KMCSHIL) median intrinsic value is ₹131.25 from 9 valuation models (range ₹45–₹376), vs current price ₹150.26 — -12.7% downside (Trading Above Median Value), margin of safety -14.5%. For current market price and key ratios, visit KMCSHIL share price screener.
KMCSHIL Valuation Methods Summary — DCF, Graham Number & P/E
KMC Speciality Hospitals intrinsic value across 9 models vs current price ₹150.26 — upside/downside and value range per method. Check KMC Speciality Hospitals market cap to track the company's total market size over time.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹45.08 | ₹36.06 - ₹54.10 | -70.0% | EPS: ₹3.40, Sector P/E: 12x |
| Book Value Method | asset | ₹131.25 | ₹118.12 - ₹144.38 | -12.7% | Book Value/Share: ₹131.25, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹168.50 | ₹151.65 - ₹185.35 | +12.1% | Revenue/Share: ₹210.62, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹300.52 | ₹270.47 - ₹330.57 | +100.0% | EBITDA: ₹106.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹375.65 | ₹300.52 - ₹450.78 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹54.38 | ₹48.94 - ₹59.82 | -63.8% | EPS Growth: 20.0%, Fair P/E: 16.0x |
| Growth Adjusted P/E | growth | ₹45.08 | ₹40.57 - ₹49.59 | -70.0% | Revenue Growth: 15.0%, Adj P/E: 8.6x |
| ROE Based Valuation | profitability | ₹300.52 | ₹270.47 - ₹330.57 | +100.0% | ROE: 26.7%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹100.20 | ₹90.18 - ₹110.22 | -33.3% | EPS: ₹3.40, BVPS: ₹131.25 |
KMCSHIL Intrinsic Value vs Market Price — All Valuation Models
KMC Speciality Hospitals fair value range ₹45–₹376 vs current market price ₹150.26 across 9 valuation models. See KMCSHIL book value comparison to compare market price against book value per share.
KMCSHIL Intrinsic Value Analysis — Undervalued or Overvalued?
KMC Speciality Hospitals median intrinsic value ₹131.25, current price ₹150.26 — Trading Above Median Value by 12.7%, margin of safety -14.5%.
What is the intrinsic value of KMCSHIL?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of KMC Speciality Hospitals (KMCSHIL) is ₹131.25 (median value). With the current market price of ₹150.26, this represents a -12.7% variance from our estimated fair value.
The valuation range spans from ₹45.08 to ₹375.65, indicating ₹45.08 - ₹375.65.
Is KMCSHIL undervalued or overvalued?
Based on our multi-method analysis, KMC Speciality Hospitals (KMCSHIL) appears to be trading above median value by approximately 12.7%.
KMCSHIL Financial Health — Key Ratios vs Industry Benchmarks
KMC Speciality Hospitals financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 1.03 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 26.7% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 30.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.02x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
KMCSHIL Cash Flow Quality — Operating & Free Cash Flow
KMC Speciality Hospitals operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹58 Cr | ₹33 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹38 Cr | ₹10 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹32 Cr | ₹8 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹29 Cr | ₹15 Cr | Positive Free Cash Flow | 7/10 |
| March 2021 | ₹26 Cr | ₹5 Cr | Positive Free Cash Flow | 7/10 |